The Human Papillomavirus (HPV) vaccine, initially recommended primarily for girls, is now strongly advised for boys as well. This shift in vaccination policy reflects a growing understanding of HPV’s impact on both sexes. The vaccine protects against several strains of HPV, which can cause various cancers, including cervical, anal, and throat cancers, as well as genital warts.

For boys, the HPV vaccine is typically recommended between the ages of 11 and 12, though it can be given as early as age 9. The vaccination series consists of two or three doses, depending on the age at which the series is started. By vaccinating boys, we not only protect them from HPV-related cancers and conditions but also contribute to herd immunity, reducing the overall prevalence of HPV in the population.

Parents should consult with their pediatrician about the appropriate timing and schedule for the HPV vaccine, considering it an essential part of their child’s preventive healthcare regimen.